BeiGene is a global biotechnology company that specializes in the development and commercialization of various medicines. It produces a range of products that treat relapsed/refractory mantle cell lymphoma, Hodgkin's lymphoma, multiple myeloma, myelodysplastic syndromes, leukemia, giant cell tumor of bone, and other ailments. In addition, it has strategic collaborations with other companies in the industry.